H Hampel, MM Mesulam, AC Cuello, et al. Revisiting the cholinergic hypothesis in Alzheimer’s disease: Emerging evidence from translational and clinical research. J Prev Alzheimers Dis. 2019, 6(1): 2-15.
TE Cope, T Rittman, RJ Borchert, et al. Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy. Brain. 2018, 141(2): 550-567.
N Musi, JM Valentine, KR Sickora, et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell. 2018, 17(6): e12840.
Y Wei, MR Shin, F Sesti. Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer’s disease. Cell Death Dis. 2018, 9(8): 820.
A Gatt, A Ekonomou, A Somani, et al. Importance of proactive treatment of depression in Lewy body dementias: The impact on hippocampal neurogenesis and cognition in a post-mortem study. Dement Geriatr Cogn Disord. 2017, 44(5–6): 283-293.
ZX Hu, WN Song, XD Lu, et al. Peripheral T lymphocyte immunity and l-dopamine in patients with Parkinson’s disease. J Biol Regul Homeost Agents. 2018, 32(3): 687-691.
AF Pardiñas, P Holmans, AJ Pocklington, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018, 50(3): 381-389.
Y Shi, S Lin, KA Staats, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018, 24(3): 313-325.
SF Sorrells, MF Paredes, A Cebrian-Silla, et al. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature. 2018, 555(7696): 377-381.
M Boldrini, CA Fulmore, AN Tartt, et al. Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell. 2018, 22(4): 589-599.
CH Nijboer, E Kooijman, CT van Velthoven, et al. Intranasal stem cell treatment as a novel therapy for subarachnoid hemorrhage. Stem Cells Dev. 2018, 27(5): 313-325.
T Kunath, A Natalwala, C Chan, et al. Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies? Eur J Neurosci. 2018, 49(4): 453-462.
JA da Silva, F Tecuapetla, V Paixão, et al. Dopamine neuron activity before action initiation gates and invigorates future movements. Nature. 2018, 554(7691): 244-248.
C Liu, L Kershberg, J Wang, et al. Dopamine secretion is mediated by sparse active zone-like release sites. Cell. 2018, 172(4): 706-718.
S Konermann, P Lotfy, NJ Brideau, et al. Transcriptome engineering with RNA-targeting Type VI-D CRISPR effectors. Cell. 2018, 173(3): 665-676.e14.
M Pignatelli, TJ Ryan, DS Roy, et al. Engram cell excitability state determines the efficacy of memory retrieval. Neuron. 2019, 101(2): 274-284.e5.
TJ Bussian, A Aziz, CF Meyer, et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature. 2018, 562(7728): 578-582.
TA Bedrosian, C Quayle, N Novaresi, et al. Early life experience drives structural variation of neural genomes in mice. Science. 2018, 359(6382): 1395-1399.
AD Levi, KD Anderson, DO Okonkwo, et al. Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury. J Neurotrauma. 2018.
LH Guadalajara, AM León, CJ Vaquero, et al. Objective demonstration of improvement of neurogenic bowel dysfunction in a case of spinal cord injury following stem cell therapy. J Surg Case Rep. 2018, 2018(11): rjy300.
J Vaquero, M Zurita, MA Rico, et al. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline. Cytotherapy. 2018, 20(6): 806-819.
J Vaquero, M Zurita, MA Rico, et al. Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyelia. Cytotherapy. 2018, 20(6): 796-805.
J Vaquero, M Zurita, MA Rico, et al. Intrathecal administration of autologous bone marrow stromal cells improves neuropathic pain in patients with spinal cord injury. Neurosci Lett. 2018, 670: 14-18.
AJ Santamaría, FD Benavides, DL DiFede, et al. Clinical and neurophysiological changes after targeted intrathecal injections of bone marrow stem cells in a C3 tetraplegic subject. J Neurotrauma. 2018, 36(3).
GA Moviglia, MTM Brandolino, D Couto, et al. Local immunomodulation and muscle progenitor cells induce recovery in atrophied muscles in spinal cord injury patients. J Neurorestoratology. 2018, 6(1): 136-145.
S Al Kandari, L Prasad, M Al Kandari, et al. Cell transplantation and clinical reality: Kuwait experience in persons with spinal cord injury. Spinal Cord. 2018, 56(7): 674-679.
NT Liem, VD Chinh, NT Thinh, et al. Improved bowel function in patients with spina bifida after bone marrow- derived mononuclear cell transplantation: A report of 2 cases. Am J Case Rep. 2018, 19: 1010-1018.
PH Sung, HS Lin, WC Lin, et al. Intra-carotid arterial transfusion of autologous circulatory derived CD34+ cells for old ischemic stroke patients - a phase I clinical trial to evaluate safety and tolerability. Am J Transl Res. 2018, 10(9): 2975-2989.
SI Savitz, D Yavagal, G Rappard, et al. A phase 2 randomized, sham-controlled trial of internal carotid artery infusion of autologous bone marrow derived ALD-401 cells in patients with recent stable ischemic stroke (RECOVER-Stroke). Circulation. 2018, 139(2): 192-205.
DT Laskowitz, ER Bennett, RJ Durham, et al. Allogeneic umbilical cord blood infusion for adults with ischemic stroke: Clinical outcomes from a phase I safety study. Stem Cells Transl Med. 2018, 7(7): 521-529.
CG van Horne, JE Quintero, JT Slevin, et al. Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson’s diseaseduring deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome. J Neurosurg. 2018, 129(6): 1550-1561.
TL Nguyen, HP Nguyen, TK Nguyen. The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy. Health Qual Life Outcomes. 2018, 16(1): 164.
C Elena, S Ekaterina, K Marina, et al. Monocyte-derived macrophages for treatment of cerebral palsy: A study of 57 cases. J Neurorestoratology. 2018, 6(1): 41-47.
L da Cruz, K Fynes, O Georgiadis, et al. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol. 2018, 36(4): 328-337.
G Mao, Y Wang, X Guo, et al. Neurorestorative effect of olfactory ensheathing cells and Schwann cells by intranasal delivery for patients with ischemic stroke: Design of a multicenter randomized double-blinded placebo-controlled clinical study. J Neurorestoratology. 2018, 6(1): 74-80.
TG Phan, H Ma, R Lim, et al. Phase 1 trial of amnion cell therapy for ischemic stroke. Front Neurol. 2018, 9: 198.
L Deng, Q Peng, H Wang, et al. Intrathecal injection of allogenic bone marrow-derived mesenchymal stromal cells in treatment of patients with severe ischemic stroke: Study protocol for a randomized controlled observer-blinded trial. Transl Stroke Res. 2018: 1-8.
T Osanai, K Houkin, S Uchiyama, et al. Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design. Int J Stroke. 2018, 13(4): 444-448.
I Garitaonandia, R Gonzalez, G Sherman, et al. Novel approach to stem cell therapy in Parkinson’s disease. Stem Cells Dev. 2018, 27(14): 951-957.
JF Loring. Autologous induced pluripotent stem cell-derived neurons to treat Parkinson’s disease.Stem Cells Dev. 2018, 27(14): 958-959.
N Cichoń, M Bijak, P Czarny, et al. Increase in blood levels of growth factors involved in the neuroplasticity process by using an extremely low frequency electromagnetic field in post-stroke patients. Front Aging Neurosci. 2018, 10: 294.
CA Angeli, M Boakye, RA Morton, et al. Recovery of over- ground walking after chronic motor complete spinal cord injury. N Engl J Med. 2018, 379(13): 1244-1250.
ML Gill, PJ Grahn, JS Calvert, et al. Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia. Nat Med. 2018, 24(11): 1677-1682.
AN Herrity, CS Williams, CA Angeli, et al. Lumbosacral spinal cord epidural stimulation improves voiding function after human spinal cord injury. Sci Rep. 2018, 8(1): 8688.
DGL Terson de Paleville, SJ Harkema, CA Angeli. Epidural stimulation with locomotor training improves body composition in individuals with cervical or upper thoracic motor complete spinal cord injury: A series of case studies. J Spinal Cord Med. 2018, 42(1): 1-7.
FB Wagner, JB Mignardot, CG Le Goff-Mignardot, et al. Targeted neurotechnology restores walking in humans with spinal cord injury. Nature. 2018, 563: 65-71.
SJ Harkema, S Wang, CA Angeli, et al. Normalization of blood pressure with spinal cord epidural stimulation after severe spinal cord injury. Front Hum Neurosci. 2018, 12: 83.
SC Aslan, BE Legg Ditterline, MC Park, et al. Epidural spinal cord stimulation of lumbosacral networks modulates arterial blood pressure in individuals with spinal cord injury- induced cardiovascular deficits. Front Physiol. 2018, 9: 565.
R Poiani, AL Zaninotto, AMC Carneiro, et al. Photobiomodulation using low-level laser therapy (LLLT) for patients with chronic traumatic brain injury: A randomized controlled trial study protocol. Trials. 2018, 19(1): 17.
JGRPD Santos, ALC Zaninotto, RA Zângaro, et al. Effects of transcranial LED therapy on the cognitive rehabilitation for diffuse axonal injury due to severe acute traumatic brain injury: Study protocol for a randomized controlled trial. Trials. 2018, 19(1): 249.
T da Silva, FC da Silva, AO Gomes, et al. Effect of photobiomodulation treatment in the sublingual, radial artery region, and along the spinal column in individuals with multiple sclerosis: Protocol for a randomized, controlled, double-blind, clinical trial. Medicine (Baltimore). 2018, 97(19):e0627.
S Falci, C Indeck, D Barnkow. Spinal cord injury below- level neuropathic pain relief with dorsal root entry zone microcoagulation performed caudal to level of complete spinal cord transection.J Neurosurg Spine. 2018, 28(6): 612-620.
H Huang, Z Al Zoubi. A brief introduction to the Special Issue on clinical treatment of spinal cord injury. J Neurorestoratology. 2018, 6: 134-135.
CC Ko, TH Tu, JC Wu, et al. Functional improvement in chronic human spinal cord injury: Four years after acidic fibroblast growth factor. Sci Rep. 2018, 8(1): 12691.
N Derakhshanrad, H Saberi, MS Yekaninejad, et al. Subcutaneous granulocyte colony-stimulating factor administration for subacute traumatic spinal cord injuries, report of neurological and functional outcomes: A double-blind randomized controlled clinical trial. J Neurosurg Spine. 2018: 1-12.
N Derakhshanrad, H Saberi, MS Yekaninejad, et al. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double- blind randomized controlled clinical trial.J Neurosurg Spine. 2018, 29(1): 97-107.
CM McDonald, B Wong, KM Flanigan, et al. Placebo- controlled phase 2 trial of drisapersen for Duchenne Muscular Dystrophy. Ann Clin Transl Neurol. 2018, 5(8): 913-926.
F Panza, D Seripa, M Lozupone, et al. The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset. Expert Opin Biol Ther. 2018, 18(1): 25-35.
KA Strauss, VJ Carson, KW Brigatti, et al. Preliminary safety and tolerability of a novel subcutaneous intrathecal catheter system for repeated outpatient dosing of nusinersen to children and adults with spinal muscular atrophy. J Pediatr Orthop. 2018, 38(10): e610-e617.
O Eckstein, CL McAtee, J Greenberg, et al. Rituximab therapy for patients with Langerhans cell histiocytosis-associated neurologic dysfunction. Pediatr Hematol Oncol. 2018: 1-7.
K Kucher, D Johns, D Maier, et al. First-in-man intrathecal application of neurite growth-promoting Anti-Nogo-A antibodies in acute spinal cord injury. Neurorehab Neural Re. 2018, 32(6–7): 578-589.
CH Hubscher, AN Herrity, CS Williams, et al. Improvements in bladder, bowel and sexual outcomes following task-specific locomotor training in human spinal cord injury. PLoS One. 2018, 13(1): e0190998.
BM Sandroff, RW Motl, M Bamman, et al. Rationale and design of a single-blind, randomised controlled trial of exercise training for managing learning and memory impairment in persons with multiple sclerosis. BMJ Open. 2018, 8(12): e023231.
C Trento, ME Bernardo, A Nagler, S Kuçi, et al. Manufacturing mesenchymal stromal cells for the treatment of graft-versus- host disease: A survey among centers affiliated with the European society for blood and marrow transplantation. Biol Blood Marrow Tr. 2018, 24(11): 2365-2370.
Q Ao, J Xiao, Y Yu, et al. Standards for the culture and quality control of umbilical cord mesenchymal stromal cells for neurorestorative clinical application (2017). J Neurorestoratology. 2018, 6: 11-15.
S Feng, J Xiao, F Han, et al. Neurorestorative clinical application standards for the culture and quality control of neural progenitor/precursor cells (version 2017). J Neurorestoratology. 2018, 6: 115-119.
EM Horwitz, K Le Blanc, M Dominici, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005, 7(5): 393-395.
M Dominici, K Le Blanc, I Mueller, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006, 8(4): 315-317.
J Galipeau, M Krampera, J Barrett, et al. International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2016, 18(2): 151-159.
H Huang, W Young, L Chen, et al. Clinical cell therapy guidelines for neurorestoration (IANR/CANR 2017). Cell Transplant. 2018, 27(2): 310-324.
M Bikson, B Paneri, A Mourdoukoutas, et al. Limited output transcranial electrical stimulation (LOTES-2017): Engineering principles, regulatory statutes, and industry standards for wellness, over-the-counter, or prescription devices with low risk. Brain Stimul. 2018, 11(1): 134-157.